New Partnership to Develop China's First SSTR4 Agonist for Pain Management Guangzhou Fermion and Simcere Pharmaceutical join forces to develop FZ002-037, the first SSTR4 agonist in China, aiming for effective pain relief.

New Partnership to Develop China's First SSTR4 Agonist for Pain Management #China #Guangzhou #Simcere #Fermion #SSTR4_Agonist

Fermion and Simcere Unite to Combat Pain with Revolutionary SSTR4 Agonist Fermion and Simcere have partnered to develop FZ002-037, China’s first SSTR4 agonist aimed at revolutionizing pain management without addiction risks.

Fermion and Simcere Unite to Combat Pain with Revolutionary SSTR4 Agonist #China #Guangzhou #Simcere #Fermion #SSTR4_Agonist